# MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

> **NCT02554279** · PHASE4 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 620 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** menotropin
- **DRUG:** recombinant FSH

## Key facts

- **NCT ID:** NCT02554279
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-31
- **Primary completion:** 2017-01-26
- **Final completion:** 2017-02-02
- **Target enrollment:** 620 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02554279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02554279, "MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT02554279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*